- 27 March
-
A meeting of the Committee on Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry was held in Ekaterinburg on March 18, 2025, chaired by Alexander Petrov. Participants of the event, including representatives of the Association of Medical Specialists for Risk Modification, the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, the Ural Biomedical Cluster and members of the Committee considered key challenges in maintaining the health of the able-bodied population, fighting against socially significant diseases and regulating prices for vital drugs.
- 05 December
-
The Russian pharmaceutical industry has gained significant stability in the recent years thanks to manufacturers such as Medsintez Plant. This is a modern full-cycle biotechnological enterprise that develops and manufactures pharmaceutical ingredients and drugs that meet international GMP and ISO standards.
- 27 September
-
On September 26, 2024, TASS hosted an expert discussion in the format of a federal teleconference Moscow-St. Petersburg-Ekaterinburg-Novosibirsk-Vologda-Anapa, dedicated to discussing the role, reasons and mechanisms for stimulating In Ekaterinburg, Alexander Petrov, the Chairman of the Board of Directors of Medsintez Plant LLC, told the participants about Triazavirin, an innovative domestic antiviral drug, as a success case of private investment in science.
- 07 September
-
60 leading Russian reproductologists visited the pharmaceutical company Medsintez Plant in Novouralsk on September 4, 2024. This event was timed to coincide with the celebration of the 3rd anniversary of the opening of the production workshop for biotechnological substances for the reproductive health of women, as well as the Annual International Conference «Reproductive Technologies Today and Tomorrow» in Ekaterinburg. Leading experts and conference speakers visited the production of the first Russian follitropin alpha for the treatment of human infertility, Primapur®.
- Home
- Cluster members
- Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC is a 100% subsidiary of NIPRO (Japan).
The company is engaged in manufacture of primary glass packaging for pharmaceutical industry.
Ampoules, vials, cartridges are made exclusively of a glass tube of the 1st hydrolytic class Type I, in accordance with European, American, Japanese pharmacopoeias, of the following brands: NSV51 (manufacturer – Nipro PharmaPackaging), Fiolax (manufacturer Schott), FS5.0 (manufacturer Four Stars, China), JUNHENG (manufacturer – Triumph Junheng, China), Corning-51-D (China).
The range of products manufactured by the company includes:
• Ampoules: 1 to 25 ml, forms B, C, D, E; made of clear and amber glass, with open point cut or cut ring, in accordance with ISO 9187 It is possible to apply marker rings to the ampoules.
• Vials: 1 to 30 ml, made of clear and amber glass, with a crimp neck, in accordance with ISO 8362
• Cartridges with a nominal capacity of 1.5; 1.8; 3 ml; made of clear glass in accordance with ISO 13926
Technological lines are equipped with options for printing on products, which allows you to apply a company logo or other information, for additional protection of medicines against counterfeiting.
In addition to standard products, the company is capable to manufacture products in accordance with individual customer drawings.
otal production capacity is up to 300 million items per year. The plant is equipped with the latest equipment: European made ampoule and vial lines by OCMI (Italy), Euromatic (Italy), NCE (Belgium), a cartridge lines of own production by NIPRO (France). All technological lines are equipped with automated quality control systems VIMEC (Netherlands), which allows rejecting products for geometric, cosmetic and mechanical defects.
The company implemented a quality management system certified in accordance with ISO 9001:2015, ISO 15378 (Special requirements for ISO 9001:2008 implementation, taking into account Good Manufacturing Practice GMP).
Ilya Markovsky,
Director
+7 (912) 242-74-99
